Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash Flows From Operating Activities    
Net loss $ (6,263) $ (3,419)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,235 873
Interest accretion 109 129
Mark to market on warrants (26) (3)
Stock-based compensation 418 538
Bad debt expense 250
Other gains and expenses, net 18
Other changes in operating assets and liabilities:    
Decrease (increase) in accounts receivable 148 (1,738)
(Increase) decrease in other current assets (1,125) 11
(Decrease) increase in accounts payable (356) 93
(Decrease) increase in accrued salaries and bonus (476) 325
(Decrease) increase in accrued liabilities (1,052) 156
Increase in long-term liabilities 16 57
Net cash used in operating activities (7,122) (2,960)
Cash Flows From Investing Activity    
Purchase of property and equipment (12)
Sale of property and equipment 13
Net cash provided by investing activity 1
Cash Flows From Financing Activities    
Issuance of common stock, net of expenses 434 6,015
Payments on Line of Credit (1,800)
Issuance of Series B preferred stock, net of expenses 19,537
Net cash provided by financing activities 18,171 6,015
Net increase in cash and cash equivalents 11,049 3,056
Cash and cash equivalents - beginning 2,321 6,068
Cash and cash equivalents - ending $ 13,370 $ 9,124